Home
About
FAQ
History (34)
Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.
Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1.
Does rural Mississippi have access to emergency neurosurgical care?
Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 µg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I).
Advances in Geriatric Hip Fractures: Pre-Operative Considerations and Tips to Optimize Outcome.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (48)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Kylie Kavanagh VMS, MPH
Wake Forest School of Medicine
Why?
Michael Olivier PhD
Wake Forest School of Medicine
Why?
Xuewei Zhu PhD
Wake Forest School of Medicine
Why?
Michael Jones DPM
Wake Forest School of Medicine
Why?
Leon Lenchik MD
Wake Forest School of Medicine
Why?
Ashley A. Weaver PhD
Wake Forest School of Medicine
Why?
Ellen E. Quillen PhD
Wake Forest School of Medicine
Why?
Suzanne Craft PhD
Wake Forest School of Medicine
Why?
Thomas Hollis PhD
Wake Forest School of Medicine
Why?
Joel D. Stitzel Jr. PhD
Wake Forest School of Medicine
Why?
Thomas C. Register PhD
Wake Forest School of Medicine
Why?
Chia-Chi C. Key PhD
Wake Forest School of Medicine
Why?
Morgana L. Mongraw-Chaffin PhD, MPH
Wake Forest School of Medicine
Why?
Herbert L. Bonkovsky MD
Wake Forest School of Medicine
Why?
Barry I. Freedman MD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 4
Next
Prev
Search Criteria
Metabolic Diseases
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions